- Home
- VRDN vs XENE Comparison
VRDN vs XENE Comparison
Compare VRDN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | XENE |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VRDN | XENE |
|---|---|---|
| Price | $18.82 | $56.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | $38.25 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,706,000.00 | $311,000.00 |
| Revenue This Year | $27.65 | N/A |
| Revenue Next Year | $253.29 | $2,436.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.90 | $26.74 |
| 52 Week High | $34.29 | $62.91 |
Technical Indicators
Market Signals| Indicator | VRDN | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 23.68 | 61.51 |
| Support Level | $17.91 | $52.55 |
| Resistance Level | $19.42 | $62.91 |
| Average True Range (ATR) | 1.12 | 1.92 |
| MACD | -1.02 | -0.22 |
| Stochastic Oscillator | 13.93 | 60.01 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.